| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/21/1994 | WO1994015934A1 Quinoline-3-acetic acid derivative, process for producing the same, and use thereof |
| 07/21/1994 | WO1994015933A1 Novel pyridone carboxylic acid derivatives |
| 07/21/1994 | WO1994015932A1 Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents |
| 07/21/1994 | WO1994015929A1 Process for the preparation of 10-desacetoxybaccatin iii |
| 07/21/1994 | WO1994015928A1 Piperazine derivatives as 5-ht antagonists |
| 07/21/1994 | WO1994015925A1 Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 07/21/1994 | WO1994015924A1 Cholecystokinin antagonists |
| 07/21/1994 | WO1994015922A1 Novel process for preparing chiral [[(2-bromoethyl)amino]methyl]-2-nitro-1h-imidazol-1-ethanol and related compounds |
| 07/21/1994 | WO1994015919A1 Piperazine derivatives |
| 07/21/1994 | WO1994015916A1 Selective ligands of receptors 5-ht1d-5ht1b derived from indole-piperazine useful as medicaments |
| 07/21/1994 | WO1994015915A1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders |
| 07/21/1994 | WO1994015914A1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders |
| 07/21/1994 | WO1994015913A1 Chemical compounds |
| 07/21/1994 | WO1994015912A1 New crystalline form of a vitamin d analogue |
| 07/21/1994 | WO1994015909A1 Amino acids and peptides having modified terminals |
| 07/21/1994 | WO1994015902A1 Compounds having selectivity for retinoid x receptors |
| 07/21/1994 | WO1994015901A1 Compounds having selectivity for retinoid x receptors |
| 07/21/1994 | WO1994015900A1 Anti-androgenic cyclo and bicyclo alkenes |
| 07/21/1994 | WO1994015898A1 Dehydrogenation processes and equipment therefor |
| 07/21/1994 | WO1994015646A1 Antisense inhibition of c-myc to modulate the proliferation of smooth muscle cells |
| 07/21/1994 | WO1994015624A1 Use of sulphated polysaccharides for preventing sexually transmitted diseases |
| 07/21/1994 | WO1994015623A1 Hyaluronic acid-urea pharmaceutical compositions and uses |
| 07/21/1994 | WO1994015619A1 OLIGONUCLEOTIDES MODIFIED TO IMPROVE STABILITY AT ACID pH |
| 07/21/1994 | WO1994015615A1 Potentiation of temozolomide in human tumour cells |
| 07/21/1994 | WO1994015614A1 Antiviral topical pharmaceutical compositions |
| 07/21/1994 | WO1994015613A1 Use of cyclooxygenase inhibitors for the manufacture of a medicament for enhancing uterine blood perfusion |
| 07/21/1994 | WO1994015612A1 Anti-atherosclerotic agents |
| 07/21/1994 | WO1994015611A1 Pharmacological stimulation of eye growth |
| 07/21/1994 | WO1994015610A1 Application of carbamazepine and oxcarbazepine in the treatment of parkinson's disease and parkinsonian syndromes |
| 07/21/1994 | WO1994015609A1 Enhanced pharmaceutical compositions for skin penetration |
| 07/21/1994 | WO1994015607A1 Application of lamotrigine in the treatment of parkinson's disease and parkinsonian syndromes |
| 07/21/1994 | WO1994015606A1 Olefin-substituted long chain compounds |
| 07/21/1994 | WO1994015604A1 Transdermal treatment of cancer with water-insoluble s-camptothecin of the closed lactone ring form |
| 07/21/1994 | WO1994015603A1 Use of idazoxan and its derivatives in the treatment of alzheimer-type senility |
| 07/21/1994 | WO1994015602A1 COMBINATION METHOD FOR TREATING PATTERNED ALOPECIA WITH 17β-N-SUBSTITUTED-CARBAMOYL-4-AZA-5α-ANDROST-1-EN-3-ONES AND MINOXIDIL |
| 07/21/1994 | WO1994015601A1 Application of riluzole in the treatment of parkinson's disease and parkinsonian syndromes |
| 07/21/1994 | WO1994015600A1 Application of riluzole as a radiorestorer |
| 07/21/1994 | WO1994015599A1 C10 taxane derivatives and pharmaceutical compositions |
| 07/21/1994 | WO1994015598A2 Methods for the improvement of cognition with functional antagonists of the glycine nmda receptor complex |
| 07/21/1994 | WO1994015597A1 Ophthalmic compositions comprising benzyllauryldimethylammonium chloride |
| 07/21/1994 | WO1994015596A1 Compositions and methods for inhibiting deoxyhypusine synthase and the growth of cells |
| 07/21/1994 | WO1994015595A1 Medium comprising a pharmacological/biological active substance |
| 07/21/1994 | WO1994015594A1 Vascularization inhibitor and novel compound |
| 07/21/1994 | WO1994015593A1 Novel parasitic helminth proteins |
| 07/21/1994 | WO1994015592A1 Compositions comprising cholesterol lowering agents and antioxidants |
| 07/21/1994 | WO1994015591A1 Onychomycosis remedy composition |
| 07/21/1994 | WO1994015586A1 Red blood cell surrogate |
| 07/21/1994 | WO1994015582A1 Topical compositions for the eye comprising a beta-cyclodextrin derivative and a carbonic anhydrase inhibitor |
| 07/21/1994 | WO1994015465A1 Compositions and uses thereof |
| 07/21/1994 | WO1994015464A1 Structured lipids |
| 07/21/1994 | WO1994015461A1 Protective skin composition |
| 07/21/1994 | WO1994012170A3 Polyunsaturated fatty acid based drugs, in particular docosahexaenoic acid, for use as platelet aggregation inhibitors and against essential fatty acid deficiencies of the brain |
| 07/21/1994 | WO1994009625A3 Stabilization of fluorocarbon emulsions |
| 07/21/1994 | WO1994007527A3 Vasoactive peptide inhibition |
| 07/21/1994 | WO1994007479A3 Immunopotentiatory agents |
| 07/21/1994 | DE4401159A1 Piperazin- und Piperidinisoxazol-Derivate Piperazine derivatives and Piperidinisoxazol |
| 07/21/1994 | CA2297592A1 Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents |
| 07/21/1994 | CA2293952A1 Preparation of esters and analogs thereof |
| 07/21/1994 | CA2153987A1 Amino acids and peptides having modified terminals |
| 07/21/1994 | CA2153698A1 Olefin-substituted long chain compounds |
| 07/21/1994 | CA2153686A1 Angiogenesis inhibitor and novel compound |
| 07/21/1994 | CA2153654A1 Growth differentiation factor-5 |
| 07/21/1994 | CA2153652A1 Growth differentiation factor-3 |
| 07/21/1994 | CA2153596A1 Methods for the improvement of cognition with functional antagonists of the glycine nmda receptor complex |
| 07/21/1994 | CA2153399A1 Use of idazoxan and its derivatives in the treatment of alzheimer-type senility |
| 07/21/1994 | CA2153341A1 Application of carbamazepine and oxcarbazepine in the treatment of parkinson's desease and parkinsonian syndroms |
| 07/21/1994 | CA2153268A1 Topical compositions for the eye comprising a .beta.-cyclodextrin derivative and a therapeutic agent |
| 07/21/1994 | CA2153228A1 Peptide inhibitors of cell adhesion |
| 07/21/1994 | CA2153166A1 Enhanced pharmaceutical compositions for skin penetration |
| 07/21/1994 | CA2153158A1 Antisense inhibition of c-myc to modulate the proliferation of smooth muscle cells |
| 07/21/1994 | CA2153147A1 Red blood cell surrogate |
| 07/21/1994 | CA2152672A1 Oligomers having improved stability at acid ph |
| 07/21/1994 | CA2152509A1 Method to predict active growth of bacteria adhered to a surface |
| 07/21/1994 | CA2152398A1 Hyaluronic acid-urea pharmaceutical compositions and uses |
| 07/21/1994 | CA2152374A1 Novel colon- or ileum-specific steroid derivatives |
| 07/21/1994 | CA2152281A1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders |
| 07/21/1994 | CA2152187A1 Anti-atherosclerotic agents |
| 07/21/1994 | CA2152185A1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders |
| 07/21/1994 | CA2152184A1 Thiazolidine derivatives; process for preparing the same and drugs containing them |
| 07/21/1994 | CA2152183A1 Pyrrolidine and thiazolidine derivatives; process for preparing the same and drugs containing them |
| 07/21/1994 | CA2151262A1 Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 07/21/1994 | CA2151029A1 Protective skin composition |
| 07/21/1994 | CA2136328A1 Novel process for preparing chiral [[(2-bromoethyl)amino] methyl]-2-nitro-1h-imidazol-1-ethanol and related compounds |
| 07/21/1994 | CA2131370A1 Quinoline-3-acetic acid derivative, process for production thereof and use thereof |
| 07/21/1994 | CA2131164A1 Method and kit for epithelial cancer screening |
| 07/21/1994 | CA2094796A1 N-methyldeacetylcolchiceinamide derivatives |
| 07/20/1994 | EP0661976A4 Defaunation method. |
| 07/20/1994 | EP0607088A1 New 17,20-epoxy pregnane derivatives, their use in the preparation of cortisone derivatives and intermediates therefor |
| 07/20/1994 | EP0607077A1 Salts of 4-pyrimidinone derivatives, their preparation and their application in therapy |
| 07/20/1994 | EP0607076A1 9H-Imidazo 1,2-a benzimidazole derivatives with GABA activity |
| 07/20/1994 | EP0607054A2 Novel process for constructing a cDNA library and a novel polypeptide and DNA coding the same |
| 07/20/1994 | EP0606985A1 Synergistic microbicidal composition comprising 3-isothiazolones and 1-methyl-3,5-7-triaza-1-azoniatricyclo(3.3.1.1)decane chloride |
| 07/20/1994 | EP0606921A1 Method of isolating haemophilus influenzae protein E |
| 07/20/1994 | EP0606869A1 Promotor sequence of the p55 tumor necrosis factor receptor |
| 07/20/1994 | EP0606824A1 Substituted dialkylthioethers |
| 07/20/1994 | EP0606756A1 Use of disulfonyl methanes for the control of parasites |
| 07/20/1994 | EP0606753A2 Non-reducing saccharide-forming enzyme, and its preparation and uses |
| 07/20/1994 | EP0606747A1 Tilmicosin and derivatives for treating gram-positive diseases of aquatic species |
| 07/20/1994 | EP0606742A1 Bile acid sequestrant |
| 07/20/1994 | EP0606723A1 Imidazolidin-2-one derivatives and their use as antitumor agents |